Triple

T9806868
Position Surface form Disambiguated ID Type / Status
Subject Chugai Pharmaceutical E238175 entity
Predicate hasSubsidiary P254 FINISHED
Object Chugai Pharma Europe
Chugai Pharma Europe is the European subsidiary of Chugai Pharmaceutical, responsible for developing, marketing, and distributing the company’s pharmaceutical products across European markets.
 E238175 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Chugai Pharma Europe | Statement: [Chugai Pharmaceutical, hasSubsidiary, Chugai Pharma Europe]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Chugai Pharma Europe
Context triple: [Chugai Pharmaceutical, hasSubsidiary, Chugai Pharma Europe]
  • A. Chugai Pharmaceutical
    Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
  • B. Eisai
    Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
  • C. Eisai
    Eisai was a Japanese Buddhist monk of the Kamakura period best known for introducing Rinzai Zen and promoting tea culture in Japan.
  • D. Mitsubishi Tanabe Pharma
    Mitsubishi Tanabe Pharma is a Japanese pharmaceutical company known for developing prescription drugs and biopharmaceuticals, including treatments for neurological and autoimmune diseases.
  • E. Takeda Pharmaceutical Company
    Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Chugai Pharma Europe
Triple: [Chugai Pharmaceutical, hasSubsidiary, Chugai Pharma Europe]
Generated description
Chugai Pharma Europe is the European subsidiary of Chugai Pharmaceutical, responsible for developing, marketing, and distributing the company’s pharmaceutical products across European markets.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: Chugai Pharma Europe
Target entity description: Chugai Pharma Europe is the European subsidiary of Chugai Pharmaceutical, responsible for developing, marketing, and distributing the company’s pharmaceutical products across European markets.
  • A. Chugai Pharmaceutical chosen
    Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
  • B. Eisai
    Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
  • C. Eisai
    Eisai was a Japanese Buddhist monk of the Kamakura period best known for introducing Rinzai Zen and promoting tea culture in Japan.
  • D. Mitsubishi Tanabe Pharma
    Mitsubishi Tanabe Pharma is a Japanese pharmaceutical company known for developing prescription drugs and biopharmaceuticals, including treatments for neurological and autoimmune diseases.
  • E. Takeda Pharmaceutical Company
    Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
  • F. None of above.

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69ca84defac48190abc1148804f184c1 completed March 30, 2026, 2:12 p.m.
NER Named-entity recognition batch_69cdab7cb9588190953a063cb7b9e29e completed April 1, 2026, 11:34 p.m.
NED1 Entity disambiguation (via context triple) batch_69d1c45a84d08190a7b5769d4a489b35 completed April 5, 2026, 2:09 a.m.
NEDg Description generation batch_69d1c57aa5e081909262cb942fdc02c5 completed April 5, 2026, 2:14 a.m.
NED2 Entity disambiguation (via description) batch_69d1c5c0e6e88190bbf6eb379e6d1aa3 completed April 5, 2026, 2:15 a.m.
Created at: March 30, 2026, 8:29 p.m.